Table 3 Positive screening of prescribed prescription drugs between sexes
Variable | Women | Men | ||
|---|---|---|---|---|
Positive screening prescription drugs | Non- prescribed (% of positive tests) | Positive screening prescription drugs | Non- prescribed (% of positive tests) | |
At least one of the following | 90 (48.4%) | 38 (43.7%) | 88 (43.4%) | 33 (36.3%) |
Benzodiazepine derivatives | 59 (31.7%) | 25 (42.4%) | 60 (30.3%) | 25 (41.6%) |
Zopiclone | 23 (12.4%) | 9 (39.1%) | 17 (8.6%) | 4 (23.5%) |
Morphine | 3 (1.6%) | 1 (33.3%) | 2 (1%) | - |
Codeine | 5 (2.7%) | 3 (60%) | 6 (3%) | 1 (16.6%) |
Methadone | - | - | 3 (1.5%) | 3 (100) |